Albert I. Wertheimer, PhD, MBA
Advertisement
Articles by Albert I. Wertheimer, PhD, MBA
Advertisement
Latest Updated Articles
- Indirect Cost of Ischemic Heart Disease to Employers
Published: January 1st 2001 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
2
FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5
